Cheng WC, Lin CC, Liao WC, Lin YC, et al. The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study. BMC Cancer 2024;24:228.
PMID: 38373960